These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3046895)

  • 1. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis in Somalia. Circulating antibodies as measured by DAT, immunofluorescence and ELISA.
    Shiddo SA; Mohamed AA; Huldt G; Loftenius A; Nilsson L; Jonsson J; Ouchterlony O; Thorstensson R
    Trop Geogr Med; 1995; 47(2):68-73. PubMed ID: 8592766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of anti-Leishmania antibodies in parenteral drug addicts. Yield value of 2 study techniques].
    Gutiérrez J; Maroto MC; Piédrola G; Higuera A
    Med Clin (Barc); 1993 Feb; 100(5):168-70. PubMed ID: 8450694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.
    Muazzam N; Rahman KM; Miah RA; Asna SM
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):77-81. PubMed ID: 1303085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases.
    Dutta GD; Dutta GP
    J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of IgG3 and IgG4 subclass in paediatric cases of kala azar.
    Ansari NA; Kumar R; Raj A; Salotra P
    Parasite Immunol; 2008 Aug; 30(8):403-9. PubMed ID: 18466200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral leishmaniasis contracted in Europe (kala-azar)].
    Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
    Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of serological tests in Indian kala-azar.
    Sinha R; Sehgal S
    J Trop Med Hyg; 1994 Dec; 97(6):333-40. PubMed ID: 7966534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid accurate field diagnosis of Indian visceral leishmaniasis.
    Sundar S; Reed SG; Singh VP; Kumar PC; Murray HW
    Lancet; 1998 Feb; 351(9102):563-5. PubMed ID: 9492776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic problems of kala azar in non-endemic area.
    Datta U; Gupta S; Arora S; Sehgal S
    Indian J Pathol Microbiol; 1987 Jan; 30(1):23-9. PubMed ID: 3315993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.